-
In Manchester, people say City scandal is 'shame for football'
-
Haze pushes Kuala Lumpur, Singapore into world's most polluted cities
-
Stocks lacklustre as inflation data weighs on sentiment
-
Dangote's $16bn Kenya refinery 'new chapter' for Africa
-
Israel-bound plane rerouted, pilots wounded in reported fight
-
Ireland coach Hallgrimsson confirms second Israel game will go ahead
-
Truth commission on Sweden's Sami people seeks redress
-
Swift concert attack plan convict fails to get Disney damages
-
Energy costs spark inflation surges in France, Italy
-
Ocon to leave Haas at end of F1 season
-
South Korea break China hearts to reach Asian Games football final
-
Indonesia razes poolside prison 'villas' where whisky, TVs seized
-
Eala storms into Asian Games semi-finals to thrill adoring fans
-
Japan court rules human voice is protected in TikTok AI case
-
Turkey freezes ex-minister's assets as fund crisis grows
-
French inflation jumps to 3% in September on energy costs
-
What we know about the North Korean POW dispute
-
South Korea score late to reach Asian Games football final
-
Most equities rise after oil price plunge, US data in focus
-
Tom Kim defies jet-lag, Kho cards ace as Asian Games golf begins
-
Polar oceans transformed as warming melts ice habitats: research
-
Thai teen rocker Nene aims to tour, write music... and return to school
-
Lost shark becomes viral star in South Korea
-
Ivory Coast clamps down on harmful illegal gold rush
-
Dangote to launch $16bn refinery in Kenya
-
Nagoya mayor says sorry for Asian Games 'inconveniences'
-
North Korean leader 'extremely obese': Seoul spy agency
-
G20 trade officials meet under shadow of tariffs, overcapacity
-
Yankees and pope-backed White Sox start MLB playoffs with wins
-
India's fat dog vote goes viral
-
Malaysia's ex-PM Mahathir in hospital for observation
-
Asian Games crowds in spotlight as 998 see hosts in 50,000 stadium
-
'No limits': Marathon world record holder Sawe chasing history
-
The eight stadiums for the 2027 Rugby World Cup
-
Countdown begins to biggest-ever Rugby World Cup
-
Thieves swipe drugs under nose of Fiji police, swap with flour
-
Bangladesh women lose ground after quota reform
-
South Korea demands North apologise for DMZ mine blasts
-
Vietnam admits 'differing opinions' on Hanoi development
-
In Nepal's flood zone, teachers mourn students who never returned
-
Stocks temper gains as oil pares heavy losses, US data in focus
-
US Supreme Court lifts limits on third-country deportations
-
New Zealand denies breaching climate commitments to EU
-
Antonelli eager to 're-establish order' as F1 returns to Malaysia
-
Albert becomes youngest US scorer in 4-2 win over Chile
-
Paw-fect candidate: Australia finds new koala rescue dog
-
Pirate island's plunging population shows Greece's demographic decline
-
One third of world population exposed to harmful air pollution: monitor
-
With elections ahead, Latvia's Russian-speakers reject Moscow's help
-
North Korea denies South's claim it was apparently behind DMZ mine blasts
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
P.A.Mendoza--AT